wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q27023579-0FA5EC6F-7ED4-497D-AA82-3B38F6832F38
Q27023579-0FA5EC6F-7ED4-497D-AA82-3B38F6832F38
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27023579-0FA5EC6F-7ED4-497D-AA82-3B38F6832F38
Metronomic chemotherapy: an attractive alternative to maximum tolerated dose therapy that can activate anti-tumor immunity and minimize therapeutic resistance
P2860
Q27023579-0FA5EC6F-7ED4-497D-AA82-3B38F6832F38
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27023579-0FA5EC6F-7ED4-497D-AA82-3B38F6832F38
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b2d8e8027489a7d71986ea28f4d2f303405041de
P2860
Phase II clinical trial results involving treatment with low-dose daily oral cyclophosphamide, weekly vinblastine, and rofecoxib in patients with advanced solid tumors.